Europe accelerates AI drug discovery as DeepMind spinoff targets trials this yearIsomorphic Labs aims to start clinical trials for AI-designed drugs by the end of this year.
Formation Bio raises $372M to boost drug development with AI | TechCrunchFormation Bio raised $372 million in Series D funding round led by Andreessen Horowitz, totaling $528 million, focusing on AI drug discovery and partnerships.
Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive | TechCrunchIsomorphic Labs has raised $600 million to enhance its AI drug discovery efforts and support clinical trials.
Europe accelerates AI drug discovery as DeepMind spinoff targets trials this yearIsomorphic Labs aims to start clinical trials for AI-designed drugs by the end of this year.
Formation Bio raises $372M to boost drug development with AI | TechCrunchFormation Bio raised $372 million in Series D funding round led by Andreessen Horowitz, totaling $528 million, focusing on AI drug discovery and partnerships.
Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive | TechCrunchIsomorphic Labs has raised $600 million to enhance its AI drug discovery efforts and support clinical trials.
Alphabet's Isomorphic Labs raises $600M in first funding round for AI drug businessIsomorphic Labs raised $600 million to enhance AI-driven drug development, aspiring to revolutionize disease treatment and accelerate medical breakthroughs.
Reid Hoffman's Manas AI raises $24.6M, a fraction of other AI drug discovery startups | TechCrunchManas AI, co-founded by Reid Hoffman, is an AI-driven startup focusing on drug discovery for major cancers, raising $24.6 million in seed funding.